ANNX
Annexon, Inc.
Company overview
- Market capitalization
- —
- Employees
- 93
- Latest publication
- 2026-09-29
About Annexon, Inc.
Annexon, Inc., a clinical-stage biopharmaceutical company, discovers and develops medicines for treating inflammatory-related diseases. The company provides Tanruprubart, an investigational full-length monoclonal antibody, which is in Phase 3 clinical trial for the treatment of patients with guillain-barré syndrome; completed Phase II clinical trial for treating Huntington's disease; and in Phase 2a clinical trial for the treatment of amyotrophic lateral sclerosis. It is also developing ANX007, an antigen-binding fragment (Fab) that is in Phase 3 program for the treatment of patients with geographic atrophy; and ANX1502, a novel oral small molecule inhibitor, which is in Phase 1 clinical trials for autoimmune indications. In addition, it develops ANX009, a C1q-blocking Fab that is in Phase I clinical trial for treating patients with lupus nephritis. The company was incorporated in 2011 and is headquartered in Brisbane, California.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 3,404,000USD | 0USD | 0USD |
| Cost Of Revenue | 957,000USD | 945,000USD | — | 912,000USD | 896,000USD | — | 870,000USD | 856,000USD |
| Gross Profit | -957,000USD | -945,000USD | — | -912,000USD | -896,000USD | 1,702,000USD | -870,000USD | -856,000USD |
| Research Development | 35,786,000USD | 42,659,000USD | 49,700,000USD | 44,160,000USD | 48,179,000USD | 43,354,000USD | 30,105,000USD | 25,026,000USD |
| Selling General Administrative | 10,267,000USD | 8,214,000USD | 7,318,000USD | 6,951,000USD | 9,226,000USD | 6,527,000USD | 9,337,000USD | 7,917,000USD |
| Total Operating Expenses | 45,096,000USD | 49,313,000USD | 57,018,000USD | 51,726,000USD | 57,405,000USD | 52,479,000USD | 39,442,000USD | 33,580,000USD |
| Operating Income | -46,053,000USD | -50,258,000USD | -57,018,000USD | -51,726,000USD | -57,405,000USD | -52,479,000USD | -39,442,000USD | -33,580,000USD |
| Interest Income | 1,911,000USD | 2,002,000USD | 2,096,000USD | 2,570,000USD | 3,049,000USD | 3,889,000USD | 4,618,000USD | 3,970,000USD |
| Net Interest Income | 1,911,000USD | 2,002,000USD | 2,096,000USD | 2,570,000USD | 3,049,000USD | 3,889,000USD | 4,618,000USD | 3,970,000USD |
| Income Before Tax | -44,142,000USD | -48,256,000USD | -54,922,000USD | -49,156,000USD | -54,356,000USD | -48,590,000USD | -34,824,000USD | -29,610,000USD |
| Net Income | -44,142,000USD | -48,256,000USD | -54,922,000USD | -49,156,000USD | -54,356,000USD | -48,590,000USD | -34,824,000USD | -29,610,000USD |
| Net Income From Continuing Ops | -44,142,000USD | -48,256,000USD | -54,922,000USD | -49,156,000USD | -54,356,000USD | -48,590,000USD | -34,824,000USD | -29,610,000USD |
| Ebit | -46,053,000USD | -50,258,000USD | -54,922,000USD | -51,726,000USD | -57,405,000USD | -52,479,000USD | -39,442,000USD | -33,580,000USD |
| Ebitda | -45,096,000USD | -49,313,000USD | -54,376,000USD | -51,111,000USD | -56,868,000USD | -51,942,000USD | -38,904,000USD | -32,943,000USD |
| Depreciation And Amortization | 957,000USD | 945,000USD | 546,000USD | 615,000USD | 537,000USD | 537,000USD | 538,000USD | 637,000USD |
| Reconciled Depreciation | 539,000USD | 543,000USD | 546,000USD | 540,000USD | 537,000USD | 537,000USD | 538,000USD | 537,000USD |
| Total Other Income Expense Net | 1,911,000USD | 2,002,000USD | 2,096,000USD | 2,570,000USD | 3,049,000USD | 3,889,000USD | 4,618,000USD | 3,970,000USD |
| Unclassified Operating Expenses | — | -1,560,000USD | — | — | — | 2,598,000USD | — | — |
| Selling And Marketing Expenses | — | — | — | — | — | — | — | 856,000USD |
| Income Tax Expense | — | — | — | — | — | — | — | 1USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Cost Of Revenue | 3,686,000USD | 3,454,000USD | 3,267,000USD | 3,311,000USD | 3,414,000USD | 667,000USD | 493,000USD | 488,000USD |
| Gross Profit | -3,686,000USD | -3,454,000USD | -3,267,000USD | -3,311,000USD | -3,414,000USD | -667,000USD | -493,000USD | -488,000USD |
| Research Development | 184,698,000USD | 119,448,000USD | 113,756,000USD | 112,501,000USD | 100,066,000USD | 49,271,000USD | 24,524,000USD | 15,528,000USD |
| Selling General Administrative | 31,709,000USD | 34,625,000USD | 28,021,000USD | 33,098,000USD | 30,647,000USD | 14,198,000USD | 7,994,000USD | 3,619,000USD |
| Unclassified Operating Expenses | -3,686,000USD | -3,454,000USD | — | — | — | — | — | — |
| Total Operating Expenses | 212,721,000USD | 150,619,000USD | 143,723,000USD | 145,599,000USD | 130,713,000USD | 63,469,000USD | 32,518,000USD | 19,147,000USD |
| Operating Income | -216,407,000USD | -154,073,000USD | -143,723,000USD | -145,599,000USD | -130,713,000USD | -63,469,000USD | -32,518,000USD | -19,147,000USD |
| Interest Income | 9,717,000USD | 15,873,000USD | 9,680,000USD | 3,652,000USD | 390,000USD | 57,000USD | 14,000USD | 40,000USD |
| Net Interest Income | 9,717,000USD | 15,873,000USD | 9,680,000USD | 3,652,000USD | 390,000USD | 57,000USD | — | — |
| Income Before Tax | -206,690,000USD | -138,200,000USD | -134,237,000USD | -141,947,000USD | -130,323,000USD | -63,412,000USD | -37,179,000USD | -18,303,000USD |
| Net Income | -206,690,000USD | -138,200,000USD | -134,237,000USD | -138,295,000USD | -127,792,000USD | -62,745,000USD | -37,183,000USD | -18,304,000USD |
| Net Income From Continuing Ops | -206,690,000USD | -138,200,000USD | -140,729,000USD | -145,599,000USD | -130,713,000USD | -63,412,000USD | -37,183,000USD | -18,304,000USD |
| Ebit | -216,407,000USD | -138,200,000USD | -143,723,000USD | -145,599,000USD | -130,713,000USD | -63,469,000USD | -32,518,000USD | -19,147,000USD |
| Ebitda | -213,757,000USD | -134,746,000USD | -141,575,000USD | -143,493,000USD | -128,572,000USD | -62,802,000USD | -32,025,000USD | -18,659,000USD |
| Depreciation And Amortization | 2,650,000USD | 3,454,000USD | 2,148,000USD | 2,106,000USD | 2,141,000USD | 667,000USD | 493,000USD | 488,000USD |
| Reconciled Depreciation | 2,166,000USD | 2,150,000USD | 2,140,000USD | 2,106,000USD | 2,141,000USD | 667,000USD | 493,000USD | 488,000USD |
| Total Other Income Expense Net | 9,717,000USD | 15,873,000USD | 9,486,000USD | 3,652,000USD | 390,000USD | 57,000USD | -4,661,000USD | 844,000USD |
| Selling And Marketing Expenses | — | — | 3,267,000USD | — | — | — | — | — |
| Interest Expense | — | — | — | 3,652,000USD | 2,141,000USD | 0USD | 4,661,000USD | 0USD |
| Income Tax Expense | — | — | — | -3,652,000USD | -2,531,000USD | -667,000USD | 4,000USD | 1,000USD |
| Net Income Applicable To Common Shares | — | — | — | -141,947,000USD | -130,323,000USD | -70,336,000USD | -38,278,000USD | -18,480,000USD |
| Tax Provision | — | — | — | — | -5,000USD | 6,000USD | 4,000USD | 1,000USD |
| Non Operating Income Net Other | — | — | — | — | — | 57,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q2 20262026-06-30 · USD | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 246,068,000USD | 262,888,000USD | 277,571,000USD | 229,142,000USD | 264,573,000USD | 303,027,000USD | 350,071,000USD | 378,776,000USD |
| Cash And Equivalents | 199,270,000USD | — | — | — | — | — | — | — |
| Total Current Assets | 212,757,000USD | 228,266,000USD | 242,191,000USD | 192,822,000USD | 230,620,000USD | 268,162,000USD | 316,461,000USD | 344,292,000USD |
| Other Current Assets | 3,514,000USD | 3,241,000USD | 3,846,000USD | 4,101,000USD | 3,603,000USD | 4,466,000USD | 4,444,000USD | 4,176,000USD |
| Other Non Current Assets | 8,271,000USD | — | — | — | — | — | — | — |
| Total Liabilities | 60,007,000USD | — | — | — | — | — | — | — |
| Total Current Liabilities | 38,482,000USD | 35,937,000USD | 42,630,000USD | 43,580,000USD | 40,642,000USD | 33,547,000USD | 30,512,000USD | 20,046,000USD |
| Total Stockholder Equity | 186,061,000USD | 204,533,000USD | 211,648,000USD | 161,442,000USD | 199,017,000USD | 243,788,000USD | 293,105,000USD | 331,560,000USD |
| Total Equity Including Noncontrolling Interest | 186,061,000USD | — | — | — | — | — | — | — |
| Property Plant Equipment Net | 24,008,000USD | 24,874,000USD | 25,802,000USD | 26,739,000USD | 27,624,000USD | 28,536,000USD | 29,343,000USD | 30,219,000USD |
| Accounts Payable | 15,731,000USD | 17,529,000USD | 14,931,000USD | 18,219,000USD | 11,515,000USD | 10,437,000USD | 10,426,000USD | 6,748,000USD |
| Short Term Debt | 3,126,000USD | 3,016,000USD | 2,908,000USD | 2,818,000USD | 2,716,000USD | 2,616,000USD | 2,518,000USD | 2,437,000USD |
| Common Stock | 175,000USD | 162,000USD | 149,000USD | 115,000USD | 110,000USD | 109,000USD | 109,000USD | 106,000USD |
| Retained Earnings | -1,016,879,000USD | -961,531,000USD | -917,389,000USD | -869,133,000USD | -814,211,000USD | -765,055,000USD | -710,699,000USD | -662,109,000USD |
| Accumulated Other Comprehensive Income | -82,000USD | -81,000USD | -29,000USD | -76,000USD | -93,000USD | -91,000USD | 10,000USD | 77,000USD |
| Total Liab | — | 58,355,000USD | 65,923,000USD | 67,700,000USD | 65,556,000USD | 59,239,000USD | 56,966,000USD | 47,216,000USD |
| Other Current Liab | — | 15,392,000USD | 24,791,000USD | 22,543,000USD | 26,411,000USD | 20,494,000USD | 17,568,000USD | 10,861,000USD |
| Capital Stock | — | 162,000USD | 149,000USD | 115,000USD | 110,000USD | 109,000USD | 109,000USD | 106,000USD |
| Cash | — | 175,208,000USD | 162,051,000USD | 139,419,000USD | 132,288,000USD | 97,122,000USD | 49,498,000USD | 79,540,000USD |
| Cash And Short Term Investments | — | 225,025,000USD | 238,345,000USD | 188,721,000USD | 227,017,000USD | 263,696,000USD | 312,017,000USD | 340,116,000USD |
| Net Debt | — | -149,774,000USD | -135,850,000USD | -112,481,000USD | -104,658,000USD | -68,814,000USD | -20,526,000USD | -49,933,000USD |
| Short Long Term Debt Total | — | 25,434,000USD | 26,201,000USD | 26,938,000USD | 27,630,000USD | 28,308,000USD | 28,972,000USD | 29,607,000USD |
| Short Term Investments | — | 49,817,000USD | 76,294,000USD | 49,302,000USD | 94,729,000USD | 166,574,000USD | 262,519,000USD | 260,576,000USD |
| Property Plant Equipment Gross | — | 34,758,000USD | 35,147,000USD | 35,541,000USD | 35,880,000USD | 36,252,000USD | 36,522,000USD | 36,861,000USD |
| Common Stock Shares Outstanding | — | 194,200,100shares | 155,105,832shares | 149,123,701shares | 148,320,803shares | 148,108,809shares | 147,812,160shares | 139,933,019shares |
| Non Current Assets Total | — | 34,622,000USD | 35,380,000USD | 36,320,000USD | 33,953,000USD | 34,865,000USD | 33,610,000USD | 34,484,000USD |
| Non Current Liabilities Total | — | 22,418,000USD | 23,293,000USD | 24,120,000USD | 24,914,000USD | 25,692,000USD | 26,454,000USD | 27,170,000USD |
| Non Currrent Assets Other | — | 9,748,000USD | 9,578,000USD | 9,581,000USD | 6,329,000USD | 6,329,000USD | 4,267,000USD | 4,265,000USD |
| Net Working Capital | — | 192,329,000USD | 199,561,000USD | 149,242,000USD | 189,978,000USD | 234,615,000USD | 285,949,000USD | 324,246,000USD |
| Unclassified Non Current Liabilities | — | 22,418,000USD | 23,293,000USD | 24,120,000USD | 24,914,000USD | 25,692,000USD | 26,454,000USD | 27,170,000USD |
| Unclassified Equity | — | 1,165,821,000USD | 1,128,768,000USD | 1,030,421,000USD | 1,013,101,000USD | 1,008,716,000USD | 1,003,576,000USD | 993,380,000USD |
| Source | DisclosureDeterministicFinal | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 277,571,000USD | 350,071,000USD | 297,674,000USD | 285,096,000USD | 287,040,000USD | 355,946,000USD | 49,898,000USD | 48,149,000USD |
| Other Current Assets | 3,846,000USD | 4,444,000USD | 4,144,000USD | 5,441,000USD | 4,978,000USD | 2,805,000USD | 1,396,000USD | 1,306,000USD |
| Total Liab | 65,923,000USD | 56,966,000USD | 47,118,000USD | 53,902,000USD | 55,131,000USD | 11,668,000USD | 6,368,000USD | 10,269,000USD |
| Total Stockholder Equity | 211,648,000USD | 293,105,000USD | 250,556,000USD | 231,194,000USD | 231,909,000USD | 344,278,000USD | 43,530,000USD | 37,880,000USD |
| Other Current Liab | 24,791,000USD | 17,568,000USD | 10,276,000USD | 13,628,000USD | 9,389,000USD | 6,888,000USD | 2,560,000USD | 2,055,000USD |
| Common Stock | 149,000USD | 109,000USD | 78,000USD | 48,000USD | 39,000USD | 38,000USD | 4,000USD | 4,000USD |
| Capital Stock | 149,000USD | 109,000USD | 78,000USD | 48,000USD | 39,000USD | 38,000USD | 143,988,000USD | 102,086,000USD |
| Retained Earnings | -917,389,000USD | -710,699,000USD | -572,499,000USD | -438,262,000USD | -296,315,000USD | -165,992,000USD | -102,580,000USD | -65,397,000USD |
| Cash | 162,051,000USD | 49,498,000USD | 225,110,000USD | 140,020,000USD | 74,843,000USD | 268,565,000USD | 43,931,000USD | 44,175,000USD |
| Cash And Short Term Investments | 238,345,000USD | 312,017,000USD | 259,716,000USD | 242,657,000USD | 242,715,000USD | 351,206,000USD | 43,931,000USD | 44,175,000USD |
| Total Current Assets | 242,191,000USD | 316,461,000USD | 263,860,000USD | 248,098,000USD | 247,693,000USD | 354,011,000USD | 45,406,000USD | 45,706,000USD |
| Total Current Liabilities | 42,630,000USD | 30,512,000USD | 17,928,000USD | 22,360,000USD | 21,744,000USD | 10,622,000USD | 4,931,000USD | 3,326,000USD |
| Net Debt | -135,850,000USD | -20,526,000USD | -193,755,000USD | -107,162,000USD | -40,254,000USD | -268,565,000USD | -43,931,000USD | 63,047,000USD |
| Short Term Debt | 2,908,000USD | 2,518,000USD | 2,165,000USD | 1,316,000USD | 1,202,000USD | 391,000USD | — | — |
| Short Long Term Debt Total | 26,201,000USD | 28,972,000USD | 31,355,000USD | 32,858,000USD | 34,589,000USD | — | — | 107,222,000USD |
| Short Term Investments | 76,294,000USD | 262,519,000USD | 34,606,000USD | 102,637,000USD | 167,872,000USD | 82,641,000USD | — | — |
| Accounts Payable | 14,931,000USD | 10,426,000USD | 5,487,000USD | 7,416,000USD | 11,153,000USD | 3,734,000USD | 2,371,000USD | 1,271,000USD |
| Property Plant Equipment Net | 25,802,000USD | 29,343,000USD | 32,782,000USD | 35,966,000USD | 38,181,000USD | 1,935,000USD | 2,138,000USD | 2,345,000USD |
| Property Plant Equipment Gross | 35,147,000USD | 36,522,000USD | 37,811,000USD | 35,966,000USD | 38,181,000USD | 1,935,000USD | 2,138,000USD | 2,345,000USD |
| Accumulated Other Comprehensive Income | -29,000USD | 10,000USD | -52,000USD | -372,000USD | -180,000USD | -77,000USD | -80,000USD | -66,000USD |
| Common Stock Shares Outstanding | 155,105,832shares | 137,404,145shares | 75,673,081shares | 54,673,572shares | 38,316,273shares | 16,962,398shares | 38,221,187shares | 11,452,244shares |
| Non Current Assets Total | 35,380,000USD | 33,610,000USD | 33,814,000USD | 36,998,000USD | 39,347,000USD | 1,935,000USD | 4,492,000USD | 2,443,000USD |
| Non Current Liabilities Total | 23,293,000USD | 26,454,000USD | 29,190,000USD | 31,542,000USD | 33,387,000USD | 1,046,000USD | 1,437,000USD | 6,943,000USD |
| Non Currrent Assets Other | 9,578,000USD | 4,267,000USD | 1,032,000USD | 1,032,000USD | 1,166,000USD | — | 2,354,000USD | 98,000USD |
| Net Working Capital | 199,561,000USD | 285,949,000USD | 245,932,000USD | 225,738,000USD | 225,949,000USD | 343,389,000USD | 40,475,000USD | 42,380,000USD |
| Unclassified Non Current Liabilities | 23,293,000USD | 26,454,000USD | 29,190,000USD | — | — | -1,046,000USD | -2,300,000USD | 5,140,000USD |
| Unclassified Equity | 1,128,768,000USD | 1,003,576,000USD | 822,951,000USD | 669,732,000USD | 528,326,000USD | 510,271,000USD | 2,198,000USD | 1,253,000USD |
| Other Assets | — | — | 1USD | 1,032,000USD | 1,166,000USD | — | 0USD | 98,000USD |
| Non Current Liabilities Other | — | — | — | 31,542,000USD | 33,387,000USD | — | — | — |
| Net Tangible Assets | — | — | — | 231,194,000USD | 231,909,000USD | 344,278,000USD | -100,454,000USD | -64,202,000USD |
| Unclassified Non Current Assets | — | — | — | -1,032,000USD | -1,166,000USD | — | — | — |
| Current Deferred Revenue | — | — | — | — | 9,250,000USD | 391,000USD | — | — |
| Unclassified Current Liabilities | — | — | — | — | -9,250,000USD | — | — | — |
| Deferred Long Term Liab | — | — | — | — | — | 1,046,000USD | 2,300,000USD | — |
| Other Liab | — | — | — | — | — | 1,046,000USD | 1,437,000USD | 1,803,000USD |
| Net Receivables | — | — | — | — | — | 3,000USD | 79,000USD | 225,000USD |
| Inventory | — | — | — | — | — | -3,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -44,142,000USD | -48,256,000USD | -54,922,000USD | -49,156,000USD | -54,356,000USD | -48,590,000USD | -34,824,000USD | -29,610,000USD |
| Depreciation | 539,000USD | 543,000USD | 546,000USD | 540,000USD | 537,000USD | 537,000USD | 538,000USD | 856,000USD |
| Stock Based Compensation | 4,156,000USD | 3,305,000USD | 3,835,000USD | 4,205,000USD | 5,078,000USD | 5,222,000USD | 4,609,000USD | 4,942,000USD |
| Other Non Cash Items | -214,000USD | -22,000USD | -88,000USD | -884,000USD | -1,491,000USD | -2,677,000USD | -2,768,000USD | -939,000USD |
| Change In Working Capital | -7,135,000USD | -1,496,000USD | -1,675,000USD | 7,224,000USD | 177,000USD | 9,493,000USD | 430,000USD | 3,898,000USD |
| Total Cash From Operating Activities | -46,796,000USD | -45,926,000USD | -52,304,000USD | -38,071,000USD | -50,055,000USD | -36,015,000USD | -32,015,000USD | -21,709,000USD |
| Capital Expenditures | 0USD | 0USD | -48,000USD | -15,000USD | -74,000USD | -6,000USD | -9,000USD | 0USD |
| Free Cash Flow | -46,796,000USD | -45,926,000USD | -52,352,000USD | -38,086,000USD | -50,129,000USD | -36,021,000USD | -32,024,000USD | -21,709,000USD |
| Investments | 27,056,000USD | -26,521,000USD | 45,871,000USD | 73,082,000USD | 97,620,000USD | 1,012,000USD | -45,926,000USD | -96,581,000USD |
| Total Cashflows From Investing Activities | 27,056,000USD | -26,521,000USD | 45,871,000USD | 73,082,000USD | 97,620,000USD | 1,012,000USD | -45,926,000USD | -96,581,000USD |
| Total Cash From Financing Activities | 32,896,000USD | 95,079,000USD | 13,564,000USD | 153,000USD | 59,000USD | 4,967,000USD | 175,000USD | 123,652,000USD |
| Issuance Of Capital Stock | 33,603,000USD | 95,370,000USD | 14,189,000USD | 0USD | 0USD | 4,634,000USD | 0USD | 124,106,000USD |
| Change In Cash | 13,156,000USD | 22,632,000USD | 7,131,000USD | 35,166,000USD | 47,624,000USD | -30,042,000USD | -77,764,000USD | 5,363,000USD |
| Begin Period Cash Flow | 163,083,000USD | 140,449,000USD | 133,320,000USD | 98,154,000USD | 50,530,000USD | 80,572,000USD | 158,336,000USD | 151,941,000USD |
| End Period Cash Flow | 176,239,000USD | 163,081,000USD | 140,451,000USD | 133,320,000USD | 98,154,000USD | 50,530,000USD | 80,572,000USD | 157,304,000USD |
| Other Cashflows From Financing Activities | 32,896,000USD | 898,000USD | -625,000USD | — | 59,000USD | 333,000USD | 175,000USD | -454,000USD |
| Unclassified Financing Cash Flow | -33,603,000USD | — | — | — | — | — | — | — |
| Dividends Paid | — | -1,857,000USD | — | — | — | — | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD | FY 20192019-12-31 · USD | FY 20182018-12-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -206,690,000USD | -138,200,000USD | -134,237,000USD | -141,947,000USD | -130,323,000USD | -63,412,000USD | -37,183,000USD | -18,304,000USD |
| Depreciation | 2,166,000USD | 2,150,000USD | 2,148,000USD | 2,106,000USD | 3,414,000USD | 667,000USD | 493,000USD | 488,000USD |
| Stock Based Compensation | 16,423,000USD | 19,433,000USD | 18,183,000USD | 18,516,000USD | 16,262,000USD | 4,888,000USD | 2,037,000USD | 408,000USD |
| Other Non Cash Items | -2,485,000USD | -7,750,000USD | -1,431,000USD | 1,278,000USD | 17,515,000USD | 53,000USD | 5,670,000USD | -260,000USD |
| Change In Working Capital | 4,230,000USD | 6,361,000USD | -5,805,000USD | 3,738,000USD | 3,284,000USD | 4,717,000USD | 625,000USD | 478,000USD |
| Total Cash From Operating Activities | -186,356,000USD | -118,006,000USD | -121,142,000USD | -116,309,000USD | -106,110,000USD | -53,087,000USD | -28,358,000USD | -17,190,000USD |
| Capital Expenditures | -137,000USD | -15,000USD | -193,000USD | -6,526,000USD | -1,654,000USD | -464,000USD | -267,000USD | -17,000USD |
| Free Cash Flow | -186,493,000USD | -118,021,000USD | -121,335,000USD | -122,835,000USD | -107,764,000USD | -53,551,000USD | -28,625,000USD | -17,207,000USD |
| Investments | 190,189,000USD | -218,797,000USD | 29,271,000USD | 64,969,000USD | -86,582,000USD | -83,164,000USD | -267,000USD | -17,000USD |
| Total Cashflows From Investing Activities | 190,052,000USD | -218,797,000USD | 70,703,000USD | 58,443,000USD | -88,236,000USD | -83,164,000USD | -267,000USD | -17,000USD |
| Total Cash From Financing Activities | 108,855,000USD | 161,206,000USD | 135,524,000USD | 122,908,000USD | 1,795,000USD | 360,876,000USD | 28,395,000USD | 58,456,000USD |
| Dividends Paid | -1,857,000USD | — | — | — | — | -102,522,000USD | — | — |
| Issuance Of Capital Stock | 109,559,000USD | 161,871,000USD | 17,545,000USD | 130,476,000USD | 0USD | 369,021,000USD | 29,997,000USD | 58,335,000USD |
| Change In Cash | 112,551,000USD | -175,612,000USD | 85,090,000USD | 65,043,000USD | -193,722,000USD | 224,634,000USD | -244,000USD | 41,209,000USD |
| Begin Period Cash Flow | 50,530,000USD | 226,142,000USD | 141,052,000USD | 76,009,000USD | 268,565,000USD | 43,931,000USD | 44,175,000USD | 2,966,000USD |
| End Period Cash Flow | 163,081,000USD | 50,530,000USD | 226,142,000USD | 141,052,000USD | 74,843,000USD | 268,565,000USD | 43,931,000USD | 44,175,000USD |
| Other Cashflows From Financing Activities | 238,000USD | -665,000USD | 14,000USD | -7,568,000USD | 1,795,000USD | 202,070,000USD | 28,395,000USD | 58,456,000USD |
| Unclassified Investing Cash Flow | — | — | 41,625,000USD | — | — | — | — | — |
| Unclassified Financing Cash Flow | — | — | 117,965,000USD | 9,080,000USD | -1,795,000USD | 266,521,000USD | -30,000,000USD | -58,456,000USD |
| Change To Liabilities | — | — | — | 5,932,000USD | 3,859,000USD | 1,513,000USD | 931,000USD | -253,000USD |
| Sale Purchase Of Stock | — | — | — | 121,396,000USD | 1,795,000USD | -5,193,000USD | 30,000,000USD | 58,456,000USD |
| Cash And Cash Equivalents Changes | — | — | — | 65,042,000USD | -192,551,000USD | 224,634,000USD | — | — |
| Other Cashflows From Investing Activities | — | — | — | 64,969USD | -86,582USD | -82,700USD | — | — |
| Net Borrowings | — | — | — | — | 0USD | — | — | — |
| Unclassified Operating Cash Flow | — | — | — | — | -16,262,000USD | — | — | — |
| Exchange Rate Changes | — | — | — | — | — | 9,000USD | — | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.